ArticleOncotarget2017
A short synthetic peptide fragment of human C2ORF40 has therapeutic potential in breast cancer.
Chaoyang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleOncotarget2017
Chaoyang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.